Business
China’s rapid growth in early-stage pharma rattles US
C&EN · By Umair Irfan ·
The Brief
- China is seeing a large increase in drug investment, drug discovery and clinical trials.
- The US faces research cuts, according to the source article.
- The source reports this shift in early-stage pharmaceutical research as a source of concern in the US.
Why it matters
Shifts in where early-stage drug research and clinical trials happen can affect the pace of new medicines, research funding decisions and international collaboration in pharmaceutical science.
Who’s affected
- pharmaceutical researchers
- science policy analysts
- US research funding stakeholders
- #pharmaceuticals
- #drug discovery
- #clinical trials
- #research funding
- #china
- #us science policy
China is seeing a huge increase in drug investment, discovery, and clinical trials while the US faces research cuts